BON Earnings Prediction
The chart below shows how BON performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BON sees a +0.00% change in stock price 10 days leading up to the earnings, and a +0.00% change 10 days following the report. On the earnings day itself, the stock moves by +0.00%. This data can give you a slight idea of what to expect for the next quarter's release.
BON Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
--
--
--
Gross Margin
--
--
--
Operating Margin
--
--
--
Net Margin
--
--
--
EPS
--
--
--
No Data Available
BON Earnings Analysis
Bon Natural Life Limited Corporation (BON.O) Earnings Conference Call
Positive
Positive Point: Bon Natural Life reported a 17.3% increase in revenue in fiscal year 2022, reaching approximately $29.9 million, driven by growth in all three product categories and an increase in average selling price. (Source: Earnings Call Transcript)
Positive Point: The company's gross profit for the fiscal year 2022 increased by 32.5% to approximately $9.4 million, primarily due to strong growth in health supplements and bioactive food ingredients. (Source: Earnings Call Transcript)
Positive Point: Bon Natural Life experienced revenue growth in all three product categories, with fragrance compounds revenue increasing by 7.6%, health supplements by 7.4%, and bioactive ingredients by 38.5% compared to the previous year. This growth was driven by higher average selling prices and volume growth. (Source: Earnings Call Transcript)
Positive Point: Despite global supply chain challenges, Bon Natural Life achieved a 21.3% increase in sales in domestic China, representing approximately 96.1% of total revenue for fiscal year 2022. The company adapted its sales strategy to focus more on domestic enterprise customers in response to the disruptions caused by COVID-19. (Source: Earnings Call Transcript)
Positive Point: Bon Natural Life has ongoing efforts in product line expansion, focusing on the regulation technology of human microorganisms to develop new products beneficial for digestive and immune health. The company plans to introduce new raw material categories and targeted mergers and acquisitions to strengthen its market position and expand globally. (Source: Earnings Call Transcript)
Negative
Negative:
- Sales volume of fragrance compounds decreased by 15.1% due to shortage of raw materials affected by abnormal weather and disruptions caused by COVID-19.
- Overseas sales represented only 3.9% of total revenue, indicating challenges in export sales due to global logistics disruptions.
- The delay in the commencement of the Yumen Plant to May 2023 may impact the company's ability to meet market demand and revenue growth expectations.
- Despite raising selling prices in response to rising raw material costs, the increase in average selling prices across product categories may impact customer demand and market competitiveness.
